Skip to main navigation
Skip to search
Skip to main content
Sort by
Nursing and Health Professions
Adverse Event
20%
Clinical Outcome
20%
Contraindication
20%
Health Care Personnel
40%
Hematopoietic Stem Cell Transplantation
100%
Household
20%
Immunocompromised Patient
100%
Immunosuppressive Treatment
100%
Inactivated Vaccine
20%
Infection
20%
Malignant Neoplasm
100%
Pediatrician
20%
Practice Guideline
20%
Professional Organization
20%
Prophylaxis
20%
Survival Rate
20%
Vaccine
20%
Vaccine Efficacy
20%
INIS
administration
11%
cancer
100%
children
100%
diseases
11%
evaluation
11%
guidelines
11%
households
11%
malignancies
11%
patients
55%
populations
11%
recommendations
11%
risks
22%
safety
11%
stem cells
100%
therapy
100%
vaccines
100%
workers
11%
Medicine and Dentistry
Adverse Event
20%
Cancer
20%
Cancer Stem Cell
100%
Contraindication
20%
Hematopoietic Stem Cell Transplantation
100%
Household
20%
Immune Response
20%
Immunocompetence
20%
Immunocompromised Patient
100%
Immunosuppressive Treatment
100%
Inactivated Vaccine
20%
Infection
20%
Pediatrician
20%
Prophylaxis
20%
Survival Rate
20%
Vaccine
20%
Immunology and Microbiology
Cancer Stem Cell
100%
Hematopoietic Stem Cell Transplantation
100%
Immune Response
20%
Immunocompetence
20%
Immunocompromised Patient
100%
Immunosuppressive Therapy
100%
Inactivated Vaccine
20%
Survival Rate
20%
Vaccine
20%
Vaccine Efficacy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
20%
Disease
20%
Immunocompromised Patient
100%
Immunosuppressive Agent
100%
Inactivated Vaccine
20%
Infection
20%
Malignant Neoplasm
100%
Survival Rate
20%
Vaccine
20%